Head-to-head · WeighScore
June Health vs NEUVÉ Health
The verdict
NEUVÉ Health takes it — 64.7/100 to 63/100, but only just.
NEUVÉ Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NEUVÉ Health sells GLP-1 care as a microdose program with a sublingual alternative, and answers the question of whether medication is inside the price three different ways on three pages. June Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | June Health | NEUVÉ Health |
|---|---|---|
| WeighScore | 63/100 | 64.7/100 |
| Grade | C | C |
| Scorecard rank | #279 | #246 |
| Semaglutide | $179/mo (starting dose, compounded) | $179/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Tirzepatide | $179/mo (starting dose, compounded) | $240/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Coverage | Coverage not published | All 50 states (claimed; the same page says members in 40+ states) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #279 · C
Strengths
- Offers both injectable and oral compounded semaglutide and tirzepatide
- Semaglutide starts at $179/mo (injectable) or $187/mo (tablets) — tirzepatide from $179/mo (injectable)
- Full per-dose price list published on-site with no signup required to view it
- Provider consult ('licensed clinician evaluation') is bundled into the displayed price
- Free discreet shipping advertised with 2-3 day delivery
Where it loses points
- No accessible Terms of Service or Privacy Policy — footer links go nowhere and standard URL guesses 404
- No LegitScript seal or other pharmacy-verification badge found anywhere on the site
- Legal entity, prescribing medical group, and compounding pharmacy partner are not named
- Domain was registered in May 2026 — a brand-new storefront with no independent reviews found
- Also sells 'MR-3' (retatrutide), a GLP-1/GIP/glucagon agonist with no FDA approval for any use
Graded #246 · C
Strengths
- The whole GLP-1 catalog is built around microdosing rather than offering it as an afterthought, with an injectable and a daily sublingual route at different prices
- Names its lab partners, Quest and LabCorp, and says panel pricing is confirmed before a charge
- States both compounding classes on the homepage rather than leaving the question open
- Names clinicians on the site and inside the matching step of the intake
- A large hormone, peptide and lab menu sits beside the GLP-1 lines
Where it loses points
- Three incompatible answers to whether medication is in the price: the weight-loss program page is headed “all-in monthly pricing” and its own fine print says medication, labs and supplies are billed separately
- Four different “from” floors are published across four pages, one of which belongs to the testosterone line rather than the GLP-1 one
- Three membership tiers — Core, Plus and Premium — are named once in the financial policy and priced nowhere
- The tirzepatide sublingual microdose card lists compounded sublingual semaglutide microdose in its own inclusion list
- Every legal page closes by saying it is plain-English summary copy under review by counsel and may change before public launch, on a site already taking intake
- “All 50 U.S. states” and “members in 40+ states” are printed on the same homepage without the distinction the About page draws
- Membership fees are non-refundable, and no pharmacy, medical group entity or NPI is named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.